Skip to main content
Fig. 3 | Diabetology & Metabolic Syndrome

Fig. 3

From: Epigallocatechin-3-gallate ameliorates hepatic damages by relieve FGF21 resistance and promotion of FGF21–AMPK pathway in mice fed a high fat diet

Fig. 3

EGCG suppressed FFAs-induced injury in hepatocytes. A, B CCK8 assay; C Immunofluorescence for lipid(× 20); D Relative expression of lipogenesis related genes in hepatocytes; Data were presented as mean ± SEM. #p < 0.05, ##p < 0.01, ###p < 0.001, ####p < 0.0001 vs BSA; *p < 0.05, **p < 0.01, ***p < 0.001, ****p < 0.0001 vs FFA. (n = 4)

Back to article page

Diabetology & Metabolic Syndrome

ISSN: 1758-5996

Contact us